PMID: 6984285Jan 1, 1982Paper

Macrophages and cancer metastasis

Advances in Experimental Medicine and Biology
I J Fidler, G Poste

Abstract

Activated macrophages appear to be able to recognize and destroy neoplastic cells without regard to their phenotypic diversity, and macrophage-mediated cytotoxicity appears invulnerable to the problem of cellular resistance to killing which is routinely encountered in efforts to destroy tumor cells by cytotoxic drugs. However, macrophage-mediated destruction of large tumor burdens may not be feasible. In many tumors the number of macrophages is too low to destroy all tumor cells, even if the macrophages are activated to the optimal tumoricidal state. For this reason, systemically administered immunomodulators encapsulated in liposomes should be used to activate macrophages to destroy those few tumor cells resistant to other means of therapy.

Citations

Jan 1, 1987·Virchows Archiv. A, Pathological Anatomy and Histopathology·P ConstantinidesS Jue
Apr 1, 1988·The International Journal of Neuroscience·M A Fitzmaurice
Mar 1, 1994·Clinical & Experimental Metastasis·C SchmidtP De Baetselier
Jan 1, 1987·Annals of the New York Academy of Sciences·R Peck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.